Safety and Efficacy Study of Misoprostol Vaginal Insert for Induction of Labour
Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study was assessment of the efficacy of four dose reservoirs (25
mcg, 50 mcg, 100 mcg, 200 mcg) of intravaginal controlled release misoprostol administered
for up to 24 hours. Efficacy was measured in terms of time from insert placement to vaginal
delivery.